NIH-funded research R21 grant

Using advanced imaging to study energy production in Alzheimer's disease

Official title: Hyperpolarized MR-PET for evaluating mitochondrial function and availability in an Alzheimers Disease Model

Funded at Massachusetts General Hospital · NIH-10867715 · Data updated 2026-11-12

This study is looking at how energy production in brain cells changes in people with Alzheimer's disease, using a special imaging technique to see these changes early on, which could help find new treatments for the condition.

More Alzheimer's Disease research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startMay 15, 2024
Project endApril 30, 2026
Funding year2024
Award (this year)$456,394
NIH project number1R21AG086721-01
Project IDNIH-10867715 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are older adults who are at risk for or have early-stage Alzheimer's disease.

Less likely to help

Patients with advanced Alzheimer's disease or those with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

What this research studies

This research investigates how mitochondrial function, which is crucial for energy production in brain cells, is affected in Alzheimer's disease. By utilizing hyperpolarized MR-PET imaging, the study aims to evaluate the availability and function of mitochondria in the brains of individuals with Alzheimer's. This approach allows researchers to observe metabolic changes that occur early in the disease process, potentially before significant symptoms appear. The findings could lead to new therapeutic strategies targeting mitochondrial dysfunction in Alzheimer's patients.

Why it matters

Potential benefit: If successful, this research could lead to earlier diagnosis and innovative treatments for Alzheimer's disease by targeting mitochondrial dysfunction.

How similar studies have gone: Previous research has shown promising results in using imaging techniques to study metabolic dysfunction in Alzheimer's, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Yen, Yi-Fen — Massachusetts General Hospital
  • Study coordinator: Yen, Yi-Fen

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.